Rockwell Medical (RMTI) EBITDA Margin Growth (5y) (2015 - 2026)
Rockwell Medical (RMTI) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Rockwell Medical | 29.81 Mn | 5.01 Mn | 3.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4,571.00 |
| Mar 31, 2026 | 3,788.00 |
| Dec 31, 2025 | 5,106.00 |
| Sep 30, 2025 | 3,384.00 |
| Jun 30, 2025 | 2,685.00 |
| Mar 31, 2025 | 4,361.00 |
| Dec 31, 2024 | 4,568.00 |
| Sep 30, 2024 | 5,839.00 |
| Jun 30, 2024 | 7,185.00 |
| Mar 31, 2024 | 5,078.00 |
| Dec 31, 2023 | 5,344.00 |
| Sep 30, 2023 | 2,267.00 |
| Jun 30, 2023 | 6,609.00 |
| Mar 31, 2023 | 3,100.00 |
| Dec 31, 2022 | 5,197.00 |
| Sep 30, 2022 | 1,452.00 |
| Jun 30, 2022 | 2,674.00 |
| Mar 31, 2022 | -712.00 |
| Dec 31, 2021 | -1,522.00 |
| Sep 30, 2021 | -652.00 |